Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Lonza Group Ltd. in Geleen, The Netherlands, is seeking a Biotech Associate to perform GMP-based cell culture and manufacturing activities.
You will execute media preparation, cell expansion and harvesting within a cleanroom, while maintaining strict aseptic practices and accurate documentation. The role requires completing laboratory training or a bachelor's degree in biotechnology, with added value from 2 years in GMP cleanrooms.
Geleen, The Netherlands Today, Lonza is a global leader in life sciences operating across five continents. While we work in science, there’s no magic formula to how we do it. Our greatest scientific solution is talented people working together, devising ideas that help businesses to help people. In exchange, we let our people own their careers. Their ideas, big and small, genuinely improve the world. And that’s the kind of work we want to be part of.
The full-time annual base pay for this position in The Netherlands is expected to range between €32.250 and €45.150. Initial salary placement within this range will be determined based on role-related factors such as experience, qualifications, and expected contribution.
At Lonza, our people are our greatest strength. With 30+ sites across five continents, our globally connected teams work together every day to manufacture the medicines of tomorrow. Our core values of Collaboration, Accountability, Excellence, Passion and Integrity reflect who we are and how we work together. Everyone’s ideas, big or small, have the potential to improve millions of lives, and that’s the kind of work we want you to be part of. Innovation thrives when people from all backgrounds bring their unique perspectives to the table. At Lonza, we value diversity and are committed to creating an inclusive environment for all employees. If you’re ready to help turn our customers’ breakthrough ideas into viable therapies, we look forward to welcoming you on board.
Ready to shape the future of life sciences?